Literature DB >> 22883696

WHO guideline development of paediatric medicines: points to consider in pharmaceutical development.

Henning G Kristensen1.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22883696     DOI： 10.1016/j.ijpharm.2012.05.054

Source DB:  PubMed          Journal:  Int J Pharm        ISSN： 0378-5173            Impact factor:   5.875


× No keyword cloud information.
  8 in total

1.  Development of taste masked caffeine citrate formulations utilizing hot melt extrusion technology and in vitro-in vivo evaluations.

Authors:  Manjeet B Pimparade; Joseph T Morott; Jun-Bom Park; Vijay I Kulkarni; Soumyajit Majumdar; S N Murthy; Zhuoyang Lian; Elanor Pinto; Vivian Bi; Thomas Durig; Reena Murthy; H N Shivakumar; K Vanaja; P C Kumar; Michael A Repka
Journal:  Int J Pharm       Date:  2015-04-15       Impact factor: 5.875

2.  Dosage form preference consultation study in children and young adults: paving the way for patient-centred and patient-informed dosage form development.

Authors:  Hamad Alyami; Eman Dahmash; Fahad Alyami; Dania Dahmash; Chi Huynh; David Terry; Afzal R Mohammed
Journal:  Eur J Hosp Pharm       Date:  2016-09-02

3.  Development of nanoparticle-based orodispersible palatable pediatric formulations.

Authors:  Yanping Deng; Lian Shen; Yan Yang; Jie Shen
Journal:  Int J Pharm       Date:  2021-01-22       Impact factor: 5.875

4.  Quantification of theophylline or paracetamol in milk matrices by high-performance liquid chromatography.

Authors:  Tânia A P Fernandes; João P Aguiar; Ana I Fernandes; João F Pinto
Journal:  J Pharm Anal       Date:  2017-07-13

5.  Children's Preferences for Oral Dosage Forms and Their Involvement in Formulation Research via EPTRI (European Paediatric Translational Research Infrastructure).

Authors:  Elisa Alessandrini; Francis Brako; Mariagiovanna Scarpa; Mariangela Lupo; Donato Bonifazi; Valeria Pignataro; Maria Cavallo; Ornela Cullufe; Cristina Enache; Begonya Nafria; Joana Claverol; Leen De Taeye; Eric Vermeulen; Jennifer Preston; Catherine Tuleu
Journal:  Pharmaceutics       Date:  2021-05-15       Impact factor: 6.321

6.  Development of an Age-Appropriate Mini Orally Disintegrating Carvedilol Tablet with Paediatric Biopharmaceutical Considerations.

Authors:  Dilawar Khan; Daniel Kirby; Simon Bryson; Maryam Shah; Afzal Rahman Mohammed
Journal:  Pharmaceutics       Date:  2021-06-03       Impact factor: 6.321

7.  Essential medicines containing ethanol elevate blood acetaldehyde concentrations in neonates.

Authors:  H C Pandya; H Mulla; M Hubbard; R L Cordell; P S Monks; S Yakkundi; J C McElnay; A J Nunn; M A Turner
Journal:  Eur J Pediatr       Date:  2016-03-21       Impact factor: 3.183

Review 8.  Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects.

Authors:  Diana A van Riet-Nales; Alfred F A M Schobben; Herman Vromans; Toine C G Egberts; Carin M A Rademaker
Journal:  Arch Dis Child       Date:  2016-03-15       Impact factor: 3.791
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.